Chen Jianzhong, Ph.D.

Department:General Surgery

Medical School:Zhejiang University School of Medicine, China

Academic Rank:Associate Professor


Clinical / Research Interests

Infection immunology: immunological pathogenesis of Hepatitis B virus and its immune prophylaxis and immunotherapy;

Tumour immunology: application of immunotherapy in cancer such as HCC.


Professional Highlights

Professional Appointments

Member, Zhejiang Society for Microbiology and Immunology 

Education Experience

Research Summary

Hepatocellular carcinomas (HCC) constantly rank among the malignancies with the highest death tolls on the global scale. Moreover, HCC are associated with a limited set of therapeutic options. A thorough comparative analysis of 282 cancer samples with 47 normal samples from GEO datasets resulted in the observation that that the level of ACADS was significantly downregulated in HCC. It was noted that ACADS was involved in the proliferation and metastasis of HCC. The TCGA database was then employed to identify tumor tissue samples which showed higher methylation levels at cg01535453, cg08618068, and cg10174836 (which are the target sites of the ACADS CpG islands) as compared with normal liver tissue samples. All these findings indicated that ACADS might be a novel methylation biomarker associated with HCC. 2010-2020

TLR plays an important role in innate immunity and its role in chronic hepatitis has received increased attention. To explore the relationship between the TLR and chronic HBV infection, we investigated the expression of TLR and related genes in hepatocytes and the interface of virus proteins of HBV such HBcAg, HBsAg in TLR signaling. The project "Regulation of IFN-beta expression of hepatocytes induced by virus PAMPs and its mechanism (Y207534)" was funded by natural science foundation of Zhejiang province.  2003.10-2010  

As a Post. D, Dr. Chen did research in IFN signaling and its function in tumor. His team found that IFN play an important role in anti-tumor by increasing the expression of p53 protein to inhibit the growth of tumour cells. 2001.10-2003.09


Publications

Chen DY, Feng XD, Lu Z, Xu XF,Lu YJ, Wu WX, Wu H, Liu H,Cao LP,Ye SY, Chen JZ, Wu J.ACADS Acts as a Potential Methylation Biomarker Associated with the Proliferation and Metastasis of Hepatocellular Carcinomas. Aging. 2019,11(20):8825-8844.

Chen DY,Wu H,He B, Lu YJ, Wu WX,Liu H, Feng XD , Chen JZ, Wu J,Five hub genes can be the potential DNA methylation biomarkers for cholangiocarcinoma using bioinformatics analysis. OncoTargets and Therapy, 2019, 12:8355-8365.

Hong BJ, Liu H, Wang ZH, Zhu YX, Su LY, Zhang MX, Xu K, Chen JZ. Inflammasome activation involved in early inflammation reaction after liver transplantation. Immunol Lett, 2017 Sep 5;190:265-271. doi: 10.1016/j.imlet.2017.08.020. 

Xia YJ, Jiang XT, Jiang SB, He XJ, Luo JG, Liu ZC, Wang L, Tao HQ, Chen JZ. PHD3 affects gastric cancer progression by negatively regulating HIF1A. Mol Med Rep. 2017;16(5):6882-6889. doi: 10.3892/mmr. 

He XJ, Tao HQ, Hu ZM, Ma YY, Xu J, Wang HJ, Xia YJ, Li L, Fei BY, Li YQ, Chen JZ.Expression of galectin-1 in CAFs promotes gastric cancer cell invasion through upregulation of integrin β1. Cancer Sci. 2014;105(11):1402-1410.


Current Program

STING as adjuvant enhancing immune response of HPV DNA vaccine and its mechanisms. Funding Source: Natural Science Foundation of Zhejiang.

Regulation of IFN-beta expression of hepatocytes induced by virus PAMPs and its mechanism. Funding Source: Natural Science Foundation of Zhejiang.

Negative regulation of immune recognition and its intervention in transplantation reject response. Funding Source: Major State Basic Research Development Program.


Find People

Search by Family Name

Find A Department

Search by Departments